The Hashgraph Association Unveils its Global Membership Program Unlocking Ecosystem Development, Partnership Engagement, and Community Collaboration

The Hashgraph Association(THA), the Swiss-based non-profit organization at the forefront of digital enablement, innovation, and education on Hedera, today unveiled its Global Membership Program-a transformative initiative designed to accelerate Web3 innovation and real-world adoption of Hedera through community collaboration, innovation, certification, and strategic partnership engagement. https://mma.prnewswire.com/media/2818531/THA_Membership.jpg Guided by Hedera's mission to empower innovators, entrepreneurs, and […]

Pomerantz LLP Advises of Securities Class Action Against CarMax, Inc. – KMX

NEW YORK CITY, NY / ACCESS Newswire / November 11, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against CarMax, Inc. ("CarMax" or the "Company") (NYSE:KMX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

JSPR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Jasper Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / November 11, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Jasper Therapeutics, Inc. ("Jasper" or "the Company") (NASDAQ:JSPR) and certain of its officers. Class Definition This lawsuit seeks to recover

MOH INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Molina Healthcare, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / November 11, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Molina Healthcare, Inc. ("Molina" or "the Company") (NYSE:MOH) and certain of its officers. Class Definition This lawsuit seeks to recover damages against

Pomerantz LLP Issues Reminder to Shareholders in Sina Corporation of Class Action – SINA

NEW YORK CITY, NY / ACCESS Newswire / November 11, 2025 / Pomerantz LLP announces that a securities fraud class action lawsuit has been filed against Sina Corporation ("Sina" or the "Company") (formerly NASDAQ:SINA) and certain of its executive officers (collectively, "Defendants") on behalf of investors who sold Sina ordinary shares, including those that sold

Pomerantz LLP Advises Shareholders of Class Action Filing Against CarMax, Inc. – KMX

NEW YORK CITY, NY / ACCESS Newswire / November 11, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against CarMax, Inc. ("CarMax" or the "Company") (NYSE:KMX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

CYTK Shareholders Have Opportunity to Lead Cytokinetics, Incorporated Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!

NEW YORK CITY, NY / ACCESS Newswire / November 11, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cytokinetics, Incorporated ("Cytokinetics" or "the Company") (NASDAQ:CYTK) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants

Pomerantz LLP Highlights Legal Filing Against Baxter International, Inc. – BAX

NEW YORK CITY, NY / ACCESS Newswire / November 11, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Baxter International, Inc. ("Baxter" or the "Company") (NYSE:BAX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

Pomerantz LLP Advises of Securities Class Action Involving Synopsys, Inc. – SNPS

NEW YORK CITY, NY / ACCESS Newswire / November 11, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Synopsys, Inc. ("Synopsys" or the "Company") (NASDAQ:SNPS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

Pomerantz LLP Highlights Class Action Against aTyr Pharma, Inc. – ATYR

NEW YORK CITY, NY / ACCESS Newswire / November 11, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against aTyr Pharma, Inc. ("aTyr" or the "Company") (NASDAQ:ATYR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

Scroll to Top